SCHEMBL3560631

SCHEMBL3560631

CC[C@H](C)[C@H](NC(=O)OC)C(=O)NN(Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.53
NR1I2 O75469 1/20 0.53
SLCO2B1 O94956 1/20 0.53
ABCB11 O95342 1/20 0.53
ABCB1 P08183 1/20 0.53
UGT1A1 P22309 1/20 0.53
CCKAR P32238 1/20 0.53
OPRK1 P41145 1/20 0.53
GHSR Q92847 1/20 0.53
SLCO1B3 Q9NPD5 1/20 0.53
ABCG2 Q9UNQ0 1/20 0.53
SLCO1B1 Q9Y6L6 1/20 0.53
CTSD P07339 4/20 0.48
CTSE P14091 1/20 0.48
PGC P20142 1/20 0.48
REN P00797 2/20 0.42
PSEN1 P49768 8/20 0.42
PSEN2 P49810 8/20 0.42
APH1B Q8WW43 8/20 0.42
NCSTN Q92542 8/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3560633 1.00 MLNR (0.53) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL3545341 0.95 UGT1A1 (0.51) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL3554832 0.95 MLNR (0.51) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL3545339 0.95 UGT1A1 (0.51) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL3554834 0.95 MLNR (0.51) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL3552162 0.90 UGT1A1 (0.70) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL3552166 0.90 UGT1A1 (0.70) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7484979 0.87 MLNR (0.52) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7483928 0.87 MLNR (0.52) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7484988 0.87 MLNR (0.52) MLNRNR1I2SLCO2B1ABCB11ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697348-B1 HIV PROTEASE INHIBITING COMPOUNDS ABBOTT LAB (US) 2011-12-28 EP disclosed
US-7696226-B2 HIV protease inhibiting compounds ABBOTT LABORATORIES (US) 2010-04-13 US disclosed
US-20050159469-A1 HIV protease inhibiting compounds ABBVIE INC. 2005-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159469-A1 HIV protease inhibiting compounds SERPINB1, HPN, DNPEP MLNR 3723/4885NR1I2 3691/4885SLCO2B1 3853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.